Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
1985-10-17
pubmed:abstractText
Singlet oxygen adducts of various vitamin D derivatives, 6,19-dihydro-6,19-epidioxyvitamin D (vitamin D endoperoxides, 2 and 2'), were chemically synthesized, and their biological activity in inducing differentiation of a human myeloid leukemia cell line (HL-60 cells) was examined. The potency of the endoperoxides derived from vitamin D derivatives possessing the 1 alpha-hydroxyl group such as 1 alpha, 25-dihydroxyvitamin D3 endoperoxides (2b and 2b') was markedly (10(-2)) diminished relative to the respective parent vitamin D compounds. In contrast, 25-hydroxyvitamin D3 endoperoxides [25-(OH)D3 endoperoxides, 2a and 2a'] and their analogues fluorinated at the 24- or 26- and 27-positions were 2.5-10 times more potent than 25-hydroxyvitamin D3 (1a) in spite of the absence of the conjugated triene structure typical of vitamin D compounds. The potency of these vitamin D endoperoxides (2 and 2'), especially those lacking the 1 alpha-hydroxyl group, in inducing differentiation of HL-60 cells was not correlated with their activity in binding to the cytosol receptor for 1 alpha, 25-dihydroxyvitamin D3 (1b). The binding efficiency to the receptor was relatively lower than the differentiating activity. To examine the action of vitamin D endoperoxides, carbon analogues of 25-(OH)D3 endoperoxides, two C-6 epimers of 25-hydroxy-6,19-dihydro-6,19-ethanovitamin D3 (6 and 6'), were synthesized. The carbon analogues (6 and 6') had no potential to induce differentiation of HL-60 cells. These results suggest that vitamin D endoperoxides (2 and 2') express their biological activity probably after being converted to some other compounds.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0022-2623
pubmed:author
pubmed:issnType
Print
pubmed:volume
28
pubmed:owner
NLM
pubmed:authorsComplete
N
pubmed:pagination
1148-53
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:2993611-Binding, Competitive, pubmed-meshheading:2993611-Calcifediol, pubmed-meshheading:2993611-Cell Differentiation, pubmed-meshheading:2993611-Cell Line, pubmed-meshheading:2993611-Chemical Phenomena, pubmed-meshheading:2993611-Chemistry, pubmed-meshheading:2993611-Cholecalciferol, pubmed-meshheading:2993611-Cytosol, pubmed-meshheading:2993611-Dose-Response Relationship, Drug, pubmed-meshheading:2993611-Humans, pubmed-meshheading:2993611-Leukemia, Myeloid, pubmed-meshheading:2993611-Oxidation-Reduction, pubmed-meshheading:2993611-Oxygen, pubmed-meshheading:2993611-Phagocytosis, pubmed-meshheading:2993611-Receptors, Calcitriol, pubmed-meshheading:2993611-Receptors, Steroid, pubmed-meshheading:2993611-Singlet Oxygen, pubmed-meshheading:2993611-Structure-Activity Relationship
pubmed:year
1985
pubmed:articleTitle
Syntheses and differentiating action of vitamin D endoperoxides. Singlet oxygen adducts of vitamin D derivatives in human myeloid leukemia cells (HL-60).
pubmed:publicationType
Journal Article, Comparative Study